Stocks and InvestingStocks and Investing
Fri, October 30, 2020
Thu, October 29, 2020
Wed, October 28, 2020
Tue, October 27, 2020

Salim Syed Maintained (BIIB) at Hold with Decreased Target to $282 on, Oct 27th, 2020


Published on 2024-10-27 14:30:51 - WOPRAI, Salim Syed
  Print publication without navigation


Salim Syed of Mizuho, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $316 to $282 on, Oct 27th, 2020.

Salim has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 3 agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020
  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020


These are the ratings of the 4 analyists that currently disagree with Salim


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $357 on, Thursday, October 22nd, 2020
  • Geoff Meacham of "B of A Securities" Maintained at Sell with Decreased Target to $235 on, Thursday, October 15th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020